Dave Lloyd

SVP, Metabolic Disease and Translational Pharmacology

Hometown:

Shropshire, UK

Education:

Ph.D. with focus on familial partial lipodystrophy, University of Leicester. Completed postdoctoral studies at the Genomics Institute of Novartis Research Foundation focused on a forward genetic approach to finding genes associated with metabolic disease.